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ABSTRACT
A new series of 2, 5 di-substituted benzimidazole derivatives have been synthesized. The structures of the synthesized 
compounds were confirmed by IR, 
1H NMR and Mass spectral analysis and they were evaluated for their antibacterial;
Proteus vulgaris (NCTC 4635), Klesibella pneumonia (ATCC 29655), Bacillus cereus (NL98), and Enterococcus faecium 
(ATCC 29212) and antifungal (Aspergillus niger and Aspergillus fumigatus) activities by disc diffusion method. All of the 
synthesized compounds showed good antibacterial and antifungal activity. However the antibacterial and antifungal activity 
of the synthesized compounds against the tested organisms was found to be less than that of respective standard drug at 
tested dose level.
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INTRODUCTION
Benzimidazole ring system known to be possess numerous 
antimicrobial 
[1-9], anti-inflammatory 
[9],  anthelmintic 
[10], 
antiviral 
[11-13] and  anti-tumour 
[14] properties.  Therefore  it 
was  enabled  that  compounds  containing  benzimidazole 
nucleus would result in interesting of biological activities. In 
the  present  study  2-substituted  benzimidazoles  were 
synthesized by treating o-phenylene diamine  with different 
carboxylic  acids.  Then  they  were  subjected  to  nitration  at 
room temperature to get 5-nitro 2-substituted benzimidazole 
derivatives. Finally they were reduced by using Zn/NaOH to 
get  5-amino  2-substituted  benzimidazole  derivatives.  The 
structures of the synthesized compounds were confirmed by 
IR, 
1H  NMR  and  Mass spectral  analysis.  The  newly 
synthesized  final  compounds  were  screened  for  their 
antibacterial and antifungal activity.
MATERIALS AND METHODS
Melting points were determined in open capillary tubes on 
melting point apparatus (Sunbim, Guna enterprises) and are 
uncorrected. The 
1H NMR spectra were recorded on Bruker-
NMR 500 mHZ using  MeOD and DMSO – d6 as solvent. 
Mass  spectra  were  recorded  on  JEOL  GC  mate  mass 
spectrometer. The IR spectra of the synthesized compounds 
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were  recorded  on  Perkin-Elmer  FT-IR  spectrophotometer 
with KBr pellets.  The UV spectra  were recorded  by using 
Double  beam  SHIMADZU  1700  UV  spectrometer.  The 
purity of the compounds was checked by TLC on pre-coated 
silica  gel  G  plates  by  using  methanol:  water  as  a  mobile 
phase and visualized in iodine vapour.
General  Method  for  the  Synthesis  of  2-substituted 
benzimidazole derivatives 
[14-15]
O-phenylene diamine (0.25 mol) and appropriate carboxylic 
acid (0.34 mol) was heated on a water bath at 100
oC for 6-8 
h. The completion of reaction was monitored by TLC. After 
completion of reaction, the reaction mixture was cooled and 
basified  to  a  pH  of  7-8  by  using  10%  sodium  hydroxide 
solution. The crude benzimidazole was filtered at the pump, 
washed with ice cold water. The crude product was dissolved 
in 400 ml of boiling water and 2 g of decolorizing carbon 
was added and digested for 15 min. The solution was filtered 
while hot, cooled the filtrate to about 10
oC. The pure product 
was filtered, washed with 25 ml of cold water and dried at 
100
oC. 
General Method for the Synthesis of 5-nitro 2-substituted 
benzimidazole derivatives 
[16]
Conc.  HNO3 (7.5  ml)  was  placed  in  three  necked  round 
bottom flask fitted with a mechanical stirrer. The flask was 
immersed in ice cold water and added slowly conc. H2SO4
(7.5  ml)  down  the  condenser  with  slow  stirring.  After  the 
addition,  2-substituted  benzimidazoles  (0.028  mol)  were 
added in a portion over a period of 1 h at such a rate that the 
temperature did not exceed  35ºC. After continuous stirring 
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crushed ice with vigorous stirring.  The formed product was 
filtered,  washed  with  cold  water  and  recrystallized  from 
ethanol. 
General  Method  for  the  Synthesis  of  5-amino  2-
substituted benzimdazole derivatives 
[17]
A solution of 0.5 g of 5-nitro, 2-substituted benzimidazoles 
in 15 ml of rectified sprit was taken in round bottom flask. 
To this, 5 ml of 20 % sodium hydroxide and 2.5 g of zinc 
dust powder was added. The reaction mixture was refluxed 
until  colour  of  the  solution  changed  from  deep  red  to 
colourless (about 4.5 h), the  hot mixture was filtered.  The 
zinc residue was returned to the flask and extracted with 10 
ml  of  hot  rectified  sprit  for  two  times.  The  extracts  were 
combined  and  the  solvent  was  removed  under  vacuum, 
yielded the brown solid and recrystallized from methanol.
Spectral data of synthesized compounds
Compound SY1: yield = 37.94%, mp 162°C, Rf = 0.79, λmax
(MeOH)  280.50,  242.5.  IR  (KBr)  cm
-1  3369.99  (N-H  str), 
3100.50 (Ar C-H str), 2539.91 (S-H str), 1661.54 (Ar C=C 
ring str), 1556.06 (C=N str).
1H NMR (MeOD) δ: 7.70 (m, 
2H; Ar-H- C4 & C7,), 7.26 (m, 2H; Ar-H- C5 & C6), 5.0 (s, 
1H; broad, NH), 3.82 (s, 2H; CH2) 1.5 (s, 1H; SH). EI-MS 
m/z 163.82 (Calcd for C8H8N2S: 164.22).
Compound SY2: yield = 39.94%, mp 112°C, Rf = 0.85, λmax
(MeOH)  275.50,  210.0.  IR  (KBr)  cm
-1 3363.57  (N-H  str), 
3032.10 (Ar C-H str), 2667.83 (C-H str), 1632.61 (C=C ring 
str),  1591.92  (C=N  str),  1320.5  (C-H  ben  gem-dimethyl), 
1272.31  (C-N  str),  1114.79  (C-C  skeletal  str). 
1H  NMR 
(MeOD) δ: 7.70 (m, 2H; Ar-H- C4& C7), 7.26 (m, 2H; Ar-H-
C5 & C6), 5.0 (s, 1H; broad, NH), 3.12 (m, 1H; CH of iso 
propyl), 1.29 (d, 6H; 2CH3 of iso propyl). EI-MS m/z: 159.90 
(Calcd for C10H12N2: 160.21). 
Compound SY3: yield = 54.02%, mp 114°C, Rf = 0.83, λmax
(MeOH)  293.50,  238.0.  IR  (KBr)  cm
-1  3192.57  (C-H  str), 
3288.94 (N-H str), 3032.75 (Ar C-H str), 1632.86 (C=C ring 
str), 1590.16 (C=N str), 1272.45 (C-N str). 
1H NMR (MeOD) 
δ: 7.70 (m, 2H; Ar-H- C4 & C7), 7.26 (m, 2H; Ar-H- C5 &
C6), 5.0 (s, 1H; broad, NH), 2.55(t, 2H; CH2), 1.62 (m, 2H; 
CH2), 1.33 (m, 2H; CH2), 0.96 (t, 3H; methyl, C11). EI-MS 
m/z: 174.24 (Calcd for C11H14N2: 170.24).
Compound SY4: yield = 35.37%, mp 248°C, Rf = 0.30, λmax
(MeOH) 294.50. IR (KBr) cm
-1 3514.74 (N-H asy str primary 
amine), 3463.63 (N-H sy str primary amine), 3358.60 (N-H 
str secondary amine), 2968.78 (Ar C-H str), 1621.12 (N-H 
ben), 1274.47 (C-N str). 
1H NMR (MeOD) δ: 7.70 (m, 2H; 
Ar-H- C4 & C7), 7.23-7.26 (m, 2H; Ar-H- C5, C6 & C2´, C6´),
6.52 (m, 2H; Ar–H- C3´&C5´), 5.0 (s, 1H; broad, NH), 4.0 (s, 
2H; NH2). EI-MS m/z: 209.18 (Calcd for C13H11N3: 209.24).
Compound SY5: yield = 31.38%, mp 254°C, Rf = 0.58, λmax
(MeOH) 273.0,  IR (KBr)  cm
-1 3114.22 (N-H str),  3062.21 
(Ar C-H str), 1604.17 (C-C skeletal str), 1541.85 (N-O asy 
str),  1349.62  (N-O  sym  str),  1288.31  (C-N  str). 
1H  NMR 
(MeOD) δ: 8.25 (m, 2H; Ar-H- C3´ & C5´), 7.74 (m, 2H; Ar-
H- C2´&C6´), 7.70 (m, 2H; Ar-H- C4 & C7), 7.26 (m, 2H; Ar-
H- C5 & C6),  5.0  (s,  1H;  broad,  NH).  EI-MS  m/z:  238.95 
(Calcd for C13H9N3O2: 239.23). 
Compound SY6: yield = 54.79%, mp 185°C, Rf = 0.81, λmax
(MeOH) 280.0, IR (KBr) cm
-1 3072.23 (Ar C-H str), 2933.61 
(S-H  str),  1683.23  (C=C  ring  str),  1584.92 (N-O  asy  str), 
1348.72 (N-O sym str), 1537.17 (C=N str), 846.68 (C-N str), 
763.10  (N-O  ben),  715.23 (C-S  str). 
1H  NMR (MeOD)  δ: 
8.63 (s, 1H; Ar-H- C4), 8.19 (d, 1H; Ar-H- C6), 7.96 (d, 1H; 
Ar-H- C7), 5.0 (s, 1H; broad, NH), 3.82 (s, 2H; CH2), 1.5 (s, 
1H; SH). EI-MS m/z: 209.11 (Calcd for C8H7N3O2S: 209.22).
Compound SY7: yield = 31.53%, mp 96°C, Rf = 0.69, λmax
(MeOH) 233.0, IR (KBr)  cm
-1 3384.19 (N-H  str),  3098.25 
(Ar  C-H  str),  1612.71  (N-H  ben),  1538.03  (N-O  asy  str), 
1348.03 (N-O sym str), 1217.67 (C-N str), 883.21 (C=C ring 
str). 
1H NMR (MeOD) δ: 8.63 (s, 1H; Ar-H- C4), 8.19 (d, 1H; 
Ar-H- C6), 7.96 (d, 1H; Ar-H- C7), 5.0 (s, 1H; broad, NH), 
3.12  (m,  1H;  CH  of  isopropyl),  1.29  (d,  6H;  2CH3 of 
isopropyl).  EI-MS  m/z:  204.88  (Calcd  for  C10H11N3O2: 
205.21). 
Compound SY8: yield = 26.59%, mp 124°C, Rf = 0.84, λmax
(MeOH) 244.0, IR (KBr)  cm
-1 3651.02 (N-H  str),  3098.41 
(Ar C-H str), 1541.67 (N-O asy str), 1344.16 (N-O sym str), 
1209.52 (C-N str), 892.90 (C=C ring str). 
1H NMR (MeOD) 
δ: 8.63 (s, 6H; Ar-H- C4), 8.19 (d, 1H; Ar-H- C5), 7.96 (d, 
1H; Ar-H- C7), 5.0 (s, 1H; broad, NH), 2.55 (t, 2H; CH2), 
1.62  (m, 2H; CH2), 1.33 (m, 2H; CH2), 0.96 (t, 2H; CH3). 
EI-MS m/z: 219.04 (Calcd for C11H13N3O2: 219.24).
Compound SY9: yield = 30.09%, mp 216°C, Rf = 0.81, λmax
(MeOH) 313.0, IR (KBr) cm
-1 3418.50 (N-H sym str primary 
amine), 3322.70 (N-H str secondary amine), 3072.36 (Ar C-
H str), 1644.22 (N-H ben), 1532.92 (N-O asy str), 1344.12 
(N-O sym str), 1231.34 (C-N str). 
1H NMR (MeOD) δ: 8.63 
(s, 1H; Ar-H- C4), 8.19 (d, 1H; Ar-H- C6), 7.96 (d, 1H; Ar-H-
C7), 7.23 (m, 2H; Ar-H- C2´& C6´), 6.52 (m, 2H; Ar-H- C3´&
C5´), 5.0 (s, 1H; broad, NH), 4.0 (s, 1H; NH2). EI-MS m/z: 
254.12 (Calcd for C13H10N4O2: 254.24).
Compound SY10: yield = 39.54%, mp 226°C, Rf = 0.58, λmax
(MeOH) 267.5, IR (KBr) Cm
-1 3114.32 (N-H str), 3061.87 
(Ar  C-H  str),  1698.28  (N-O  asy  str),  1604.29  (N-H  ben), 
1349.69 (N-O sym str), 877.69 (C-N str). 
1H NMR (MeOD) 
δ: 8.63 (s, 1H; Ar-H- C4), 8.25 (m, 2H; Ar-H- C3´ & C5´), 
8.19 (d, 1H; Ar-H- C6), 7.96 (d, 1H; Ar-H- C7), 7.74 (m, 1H; 
Ar-H- C2´& C6´), 5.0 (s, 1H; broad, NH). EI-MS m/z: 284.12 
(Calcd for C13H8N4O4: 284.22).
Compound SY11: yield = 44.04%, mp 261°C, Rf = 0.78, λmax
(MeOH, DMSO) 275.0, IR (KBr) cm
-1 3552.00 (N-H asy str 
primary  amine),  3416.86  (N-H  sym str  primary  amine), 
3376.18  (N-H  str  secondary  amine),  2468.00  (S-H  str), 
1622.56 (N-H ben), 1225.49 (C-N str), 746.41 (C-S str). 
1H 
NMR (DMSO – d6) δ: 7.31 (d, 1H; Ar-H- C7), 6.70 (s, 1H; 
Ar-H- C4), 6.62 (d, 1H; Ar-H- C6), 5.0 (s, 1H; NH), 4.03 (s, 
2H; CH2), 3.48 (s, 2H; NH2), 1.68 (s, 1H; SH). EI-MS m/z: 
179.14 (Calcd for C8H9N3S: 179.24).
Compound SY12: yield = 91.96%, mp 220°C, Rf = 0.79, λmax
(MeOH, DMSO) 272.5, IR (KBr) cm
-1 3587.00 (N-H asy str 
primary amine), 3218.00 (N-H str secondary amine), 2343.00 
(C-H  str),  1635.00 (N-H  ben),  1385.00 (C-N  str),  1129.00 
(C-H inplane ben). 
1H NMR (DMSO – d6) δ: 7.31 (d, 1H; Ar-
H- C7), 6.69 (s, 1H; Ar-H- C4), 6.61 (d, 1H; Ar-H- C6), 5.0 (s, 
1H; NH), 3.48 (s, 2H; NH2), 3.40 (m, 1H; CH of isopropyl), 
1.24 (m, 6H; CH3 of isopropyl). EI-MS m/z: 175.18 (Calcd 
for C10H13N3: 175.23).
Compound SY13: yield = 93.02%, mp 238°C, Rf = 0.80, λmax
(MeOH, DMSO) 366.0, IR (KBr) cm
-1 3573.00 (N-H asy str 
primary  amines),  3393.00  (N-H  str  secondary  amines), 
2175.00 (C-H str), 1648.00 (N-H ben), 1397.00 (C-N str). 
1H 
NMR (DMSO – d6) δ: 7.31 (d, 1H; Ar-H- C7), 6.69 (s, 1H; 
Ar-H- C4), 6.61 (d, 1H; Ar-H- C6), 5.0 (s, 1H; NH), 3.48 (s, 
2H; NH2), 2.86 (t, 2H; CH2), 1.72 (m, 2H; CH2), 1.30 (m, 
2H; CH2), 0.90 (t, 3H; CH3). EI-MS m/z: 189.22 (Calcd for 
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Scheme 1: Synthetic scheme of 5-amino 2-substituted benzimidazole 
derivatives.
Compound R
SY1, SY6, SY11 CH2SH
SY2, SY7, SY12 CH(CH3)2
SY3, SY8, SY13 CH2CH2CH2CH3
SY4, SY9, SY14 C6H6N
SY5, SY10, SY15 C6H4NO2
Compound SY14: yield = 86.36%, mp 255°C, Rf = 0.72, λmax
(MeOH, DMSO) 366.0, IR (KBr) cm
-1 3579.00 (N-H asy str 
primary amine), 3369.00 (N-H str secondary amine), 1645.00 
(N-H ben), 1429.00 (C-N str), 866.00 (C-H ben). 
1H NMR 
(DMSO – d6) δ: 7.85 (m, 2H; Ar-H- C2´ & C6´), 7.43 (d, 1H; 
Ar-H- C7), 6.85 (s, 1H; Ar-H- C4), 6.76 (d, 1H; Ar-H- C6), 
6.59 (m, 2H; Ar-H- C10 & C12), 5.0 (s, 1H; NH), 3.99 (s, 2H; 
NH2),  3.58  (s,  2H;  NH2).  EI-MS  m/z:  224.20  (Calcd  for 
C13H12N4: 224.26).
Compound SY15: yield = 39.14%, mp 277°C, Rf = 0.76, λmax
(MeOH, DMSO) 270.0, IR (KBr) cm
-1 3559.00 (N-H asy str 
primary  amine),  3432.00  (N-H  sym  str  primary  amine), 
3206.00  (N-H  str  secondary  amine),  1632.00  (N-H  ben), 
1596.00 (N-O str). 
1H NMR    (DMSO – d6) δ: 8.28 (m, 2H; 
Ar-H- C3´& C5´), 8.02 (m, 2H; Ar-H- C2´& C6´), 7. 44 (d, 1H; 
Ar-H-C7), 6.91 (s, 1H; Ar-H-C4), 6.82 (d, 1H; Ar-H- C6), 5.0 
(s, 1H; NH), 3.58 (s, 2H; NH2). EI-MS m/z: 254.12 (Calcd 
for C13H10N4O2: 254.24).
Antimicrobial Activity 
[2]
The  synthesized  compounds  were  tested  for  antimicrobial 
activity by disc diffusion method.  They were dissolved in 
DMSO and sterilized by filtering through 0.45μm millipore 
filter.  Final inoculums  of 100µl  suspension  containing 10
8
CFU/ ml of each bacterium and fungus used.  Nutrient agar 
(antibacterial  activity)  and  sabouraud’s  dextrose  agar 
medium (antifungal activity) was prepared and sterilized by 
an autoclave (121°C and 15 Ibs for 20 min) and transferred to 
previously  sterilized  petridishes  (9  cm  in  diameter).  After 
solidification,  petriplates  were  inoculated  with  bacterial 
organisms in sterile nutrient agar medium at 45
oC, and fungal 
organisms  in  sterile  sabouraud’s  dextrose  agar  medium  at 
45
oC  in  aseptic  condition.  Sterile  Whatmann  filter  paper 
discs (previously sterilized in U.V. lamp) were impregnated 
with synthesized compounds at a concentration  of 25; 100 
mg/disc were placed in the organism-impregnated petri plates 
under sterile condition. The  plates were left for 30 min to 
allow  the  diffusion  of  compounds  at  room  temperature. 
Antibiotic  discs  of  ciprofloxacin  (100µg  /disc)  and   
ketaconazole  (100µg  /disc)  were  used  as  positive  control, 
while DMSO used as negative control. Then the plates were 
incubated for 24 h at 37 ± 1°C for antibacterial activity and 
48 h at 37±1°C for antifungal activity. The zone of inhibition 
was calculated by measuring the minimum dimension of the 
zone of no microbial growth around the each disc. 
RESULTS AND DISCUSSION
The structure of the synthesized compounds were established 
by spectral (IR, 
1H NMR and Mass) analysis data. The NH 
band (3463-3114 cm
-1) and NH proton signal (5.0 ppm) of 2-
substituted  benzimidazole  in  IR  and 
1H  NMR  spectrum 
respectively  in  the  synthesized  compounds,  (SY1-SY5) 
confirmed the formation of benzimidazole nucleus. In SY1, 
1H NMR spectrum showed a 2 proton singlet at δ 1.5 and δ 
3.82 for 3 protons confirmed the presence of methane thiol 
group. In SY2, multiplet at δ 3.12 for 1 proton and doublet at 
δ  1.29 for  6  protons  indicated  the  formation  of  iso-propyl 
group. In SY3, two triplets at δ 2.55 and 0.96 for 5 protons 
and two multiplet at δ 1.62 and δ 1.37 for 4 protons indicated 
the presence of butyl group. In SY4, two multiplet at δ 7.23-
7.26 and δ 6.52 for 4 protons and a singlet at δ 4.0 for 2 
protons indicated the presence of amino phenyl group. In the 
case of SY5, two multiplet at δ 8.25 and δ 7.74 for 4 protons 
indicated  the  substitution  of  nitro  phenyl  group  at  C2  of 
benzimidazole nucleus. The presence of nitro group in SY6-
SY10 was ascertained from strong bands at 1584 -1532 cm
-1 
and 1345 cm
-1 corresponding to asymmetric and symmetric 
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Table 1: Antimicrobial activity of the synthesized compounds by disc diffusion method (SY11 – SY15)
Organisms
Diameter of  Zone of inhibition in mm
SY11 SY12 SY13 SY14 SY15 Ket Cip
25 (mg) 100 (mg) 25 (mg) 100 (mg) 25 (mg) 100 (mg) 25(mg) 100 (mg) 25 (mg) 100 
(mg)
100 
(µg)
100 
(µg)
B. cereus 11 17 17 25.5 12 14 10 14.8 18 26 ---- 30
P. vulgaris 12 18.5 12 15 21 25 11 16.4 12 17 ----- 28
K.pneumonia 13 15 14 17 18 22.5 21 26 22 26.5 ----- 29
E. faecium 15 18 14 17.6 11 14 17 21 17 24 ----- 28
A. niger 14 17.5 19 22 14 26 15 19.5 12 16.4 30 ----
A. fumigatus 15 17 20 21 15 16 11 16.7 13 18 27 -----
(Ket = Ketoconazole, Cip = Ciprofloxacin, P. vulgaris = Proteus vulgaris, K. pneumonia  = Klesibella pneumonia, B. Cereus = Bacillus cereus, E. faecium = 
Enterococcus faecium, A. niger = Aspergillus niger and A. fumigatus = Aspergillus fumigatus)
Further  a  strong  intensity  signal  at  1231-846  cm
-1  was 
attributed  to  the  C-N  stretching  for  aromatic  nitro 
compounds.  Spectrum  of  SY6-SY10 in  the  aromatic  region 
indicated that the three chemical environments at δ 8.63, 8.19 
and 7.96, instead of two regions which were present in SY1-
SY5. The presence of primary amino group in SY11-SY15 was 
ascertained from strong bands at 3500 cm
-1 and 3400 cm
-1
corresponding to asymmetric and symmetric H-N-H stretch 
respectively. Further a strong signal at 1648-1622 cm
-1 was 
attributed to N-H bending for primary amino group. In SY11 –
SY15, a singlet at δ
  3.48 for 2 protons indicated the presence 
of  primary  amino  group.  In  the  mass  spectrum  of  the 
synthesized compounds produced (M
+) molecular ion peaks 
at 163.82, 159.90, 174.24, 209.18,  238.95, 209.11, 204.88, 
219.04,  254.12,  284.12,  179.24,  175.23,  189.25,  224.26, 
254.24 values for SY1 -SY15 respectively corresponds to their 
molecular formulas. 
The synthesized compounds were evaluated for in-vitro anti-
bacterial  activity  against  gram  negative  bacteria  Proteus 
vulgaris (NCTC 4635), Klesibella pneumonia (ATCC 29655) 
and  gram  positive  bacteria  Bacillus  cereus  (NL98), 
Enterococcus faecium (ATCC 29212). These are the agents 
commonly  causes  urinary  tract  infection,  nosocomial 
infection, biliary tract infection. The gram negative organism 
Klesibella pneumonia causes pneumonia, bronco pneumonia 
and  bronchitis infection.  The  gram  negative  organisms 
Bacillus  cereus  and  Enterococcus  faecium  cause
endocarditis,  bacteremia, meningitis and septicaemia.  From 
the biological data, it was evident that the compound SY15
was found to be more active against Klesibella pneumonia 
(ATCC 29655), Bacillus cereus (NL98), and Enterococcus 
faecium (ATCC 29212); where as compound SY13 was found 
to  be  more  active  aganist Proteus  vulgaris  (NCTC  4635). 
Compound  SY12 was  found  to  be  more  active  against 
Aspergillus  niger  and  Aspergillus  fumigatus. However  the 
antimicrobial activity of the synthesized compounds against 
the  tested  organisms  was  found  to  be  less  than  that  of 
respective standard drug at tested dose level. In future study 
the  activity  of  the  compounds  may  be  manipulated  by
introducing  unsaturation  or  heterocyclic  ring  at  C2 of 
benzimidazole. 
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